Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Summary

This was a single-centre, single-arm, non-blinded, prospective study using 20 patients with advanced metastatic GI malignancies recruited to treat patients with advanced metastatic GI malignancies with 177Lu-CTR-FAPI to assess the safety of 177Lu-CTR-FAPI in advanced metastatic GI malignancies; this included radiation therapy dosimetry and initial treatment Determination of Effectiveness

Timeline

Start

2025-06-20

Primary completion

2028-04-30

Completion

2028-04-30

Drugs

Indications